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Autophagy is a cellular recycling and stress response that
degrades organelles and long-lived proteins and serves to
protect cells from the potential damage induced by dysfunc-
tional organelles and protein aggregates.1 Autophagy can
also be used as a recycling or salvage process to provide
amino acids, nucleotides and other building blocks to protect
cells from some, but not all, forms of starvation.2,3
Given that autophagy is part of the cellular stress response,
it is perhaps not surprising that this process can also influence
cell death decisions. Similar to the endoplasmic reticulum
stress response, autophagy is predominantly cytoprotective,
but excessive or persistent autophagy can also be cytotoxic.4
Similarly, the p53-dependent stress response, which is
primarily concerned with coordinating DNA damage-asso-
ciated repair, can result in apoptosis above a certain threshold
of p53 activation.5 This makes good biological sense, as cells
with excessive DNA damage are risky to repair due to the
potential for the development of cancer. Indeed, many
biological responses are governed by threshold effects, above
and below which either no response occurs or a qualitatively
different response is initiated. Other examples include
activation of Myc, Ras or B-Raf, which are normally drivers
of cell proliferation, but can promote the diametrically opposite
outcomes of apoptosis, replicative senescence or autophagic
cell death when deregulated.6–8
Thus, it is not particularly surprising that excessive
autophagy can promote cell death rather than cell survival in
several situations.4 To distinguish cell death accompanied by
signs of autophagy (i.e. ‘cell death with autophagy’) from cell
death as a consequence of autophagy, the term ‘autophagic
cell death’ is employed to define instances in which the
autophagy machinery is required for cell death.9,10 Autopha-
gic cell death has been reported during Drosophila develop-
ment11,12 in response to ischemia13,14 as a consequence of
deregulated Ras activation,15 upon inhibition of caspase-10 in
multiple myeloma,16 or upon treatment of apoptosis-deficient
cells with chemotherapeutic drugs.17
Levine and colleagues have recently characterized a form
of autophagic cell death induced by a synthetic autophagy-
inducing peptide, comprising the viral Tat peptide fused to a
small peptide sequence from Beclin-1.18 It is unclear why
the Tat-Beclin-1 peptide promotes autophagy, or indeed
autophagic cell death, or whether this mimics a bona fide
physiological stress. Nonetheless, Liu et al. have
characterized the morphological features of cell death
induced by Tat-Beclin 1, a form of cell death that can be
partially rescued by knockdown of Atg13 or Atg14, as well as
3-methyladenine. They confirmed that cell death in this
context was not apoptotic or necroptotic and also observed
the vacuolated cytoplasm characteristic of recent descriptions
of autophagic cell death.15 Moreover, a small minority (B1%)
of cells dying as a consequence of amino acid/serum
starvation presented the same morphological features as
cells treated with Tat-Beclin-1 peptide. Some of these
descriptive morphological features were also seen in a model
of in vivo permanent brain ischemia, in which neurons appear
to die with features of autophagic cell death.
A compound library screen revealed that the Naþ ,Kþ -
ATPase, an ionic pump that consumes 20% of cellular ATP
(and up to 66% in neurons), participates in autophagic cell
death in this setting. Consistent with this, cardiac glycosides—
chemical inhibitors of the Naþ ,Kþ -ATPase—prevented
autophagic cell death induced by amino acid/serum starva-
tion. Liu et al. also showed that, as reported previously in a
similar model, a cardiac glycoside (neriifolin) dramatically
reduced brain damage in neonatal rats subjected to brain
ischemia.19
Levine and colleagues have suggested that the term
‘Autosis’ be used to define the form of autophagic cell death
characterized in their study. However, it is not clear that the
introduction of a new name for this form of cell death is really
warranted. The primary case made by the authors for the
introduction of the new term (autosis) is that the term
‘autophagic cell death’ has become controversial and has
sometimes been confused with cells dying with features of
autophagy. This is as distinct from cells dying as a
consequence of excessive autophagy (i.e. autophagic cell
death). The introduction of yet another new term for a cell
death modality may not be that helpful for a number of
reasons.
First, the distinction between autophagic cell death and cell
death accompanied by features of autophagy is now well
recognized. Second, it is too early to say whether the mode of
cell death reported by Levine and colleagues represents a
physiological mode of cell death, as this has been studied
almost entirely in the context of an artificial Tat–Beclin fusion
peptide. The evidence that this mode of cell death occurs
in vivo is very preliminary and entirely descriptive. Third, when
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re-naming a process, as in this situation, there should be a
strong rationale for doing so. To do otherwise is to risk a
proliferation of new terms for what is essentially the same
process. Indeed, this has already happened to some degree
in the cell death field. Thus, we have apoptosis, necrosis,
anoikis, pyroptosis, aponecrosis, necroptosis, programmed
necrosis, autophagic cell death, entosis and countless more
names for cell death triggered under different conditions or
displaying a distinct morphology. Some forms of cell death
have even been named after compounds or stimuli that trigger
them (e.g. Ferroptosis, Anoikis, mitotic catastrophe). Here, it
is proposed that autophagic cell deaths exhibiting certain
features (i.e. mediated by autophagy genes and characterized
by focal perinuclear swelling) should be named Autosis.
However, the logic for introducing a new name for what is, in
essence, simply autophagic cell death is not particularly
compelling. For example, staurosporine is a well-known
inducer of apoptosis, but because of its properties as a kinase
inhibitor it induces an atypical apoptosis with ballooning of
cells and some features reminiscent of the early stages of
necrosis. Should this be called ‘Stauroptosis’ because of its
distinct morphological features?
At present, there does not appear to be a strong case for
the introduction of a new term to describe another example of
autophagic cell death. Perhaps if subsequent studies
determine that this subroutine of autophagic cell death is
indeed mechanistically distinct and is important under
physiological conditions, this might be appropriate. We
would note that the Cell Death Nomenclature committee
recommends that the term Autophagic Cell Death should
be used to refer to instances of cell death that ‘can be
suppressed by the inhibition of the autophagic pathway by
chemicals (e.g. agents that target VPS34) and/or genetic
means’ and are not mediated by caspases or necroptotic
mediators. Coining a new term for a subtype of cell death that
clearly fits into an existing category is unwarranted and
contributes to creating a scientific tower of Babel where it
becomes progressively difficult to know what we are all
talking about.
Notwithstanding these quibbles about the introduction of a
new term for autophagic cell death, it is possible that the
inhibitors of this process described by Levine and colleagues
may have therapeutic implications in conditions where
death by autophagy may be contributory to the underlying
pathology.
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